{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:31:42Z","timestamp":1789475502711,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ctro.2025.101011","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T19:45:03Z","timestamp":1751917503000},"page":"101011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5209-3558","authenticated-orcid":false,"given":"Nicolas","family":"Giraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"van Sornsen de Koste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.N.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5204-1774","authenticated-orcid":false,"given":"Famke L.","family":"Schneiders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Senan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.101011_b0005","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-305","article-title":"Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial","volume":"12","author":"Palma","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2025.101011_b0010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1186\/s12885-022-10419-4","article-title":"Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design","volume":"22","author":"Doppenberg","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2025.101011_b0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ijrobp.2011.11.050","article-title":"Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations","volume":"83","author":"Huguet","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2019.12.003","article-title":"MRI-based upper abdominal organs-at-risk atlas for radiation oncology","volume":"106","author":"Lukovic","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0030","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1017\/S1460396922000279","article-title":"Spleen as an organ at risk in adjuvant chemoradiotherapy for gastric cancer: a retrospective dosimetric study","volume":"22","author":"Velu","year":"2023","journal-title":"J Radiother Pract"},{"key":"10.1016\/j.ctro.2025.101011_b0035","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.ijrobp.2018.07.410","article-title":"Proposition of splenic dose-volume constraints to prevent severe lymphopenia after chemoradiation for pancreatic cancer","volume":"102","author":"Blais","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0045","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.21873\/invivo.11409","article-title":"Spleen dose\u2013volume parameters as a predictor of treatment-related lymphopenia during definitive chemoradiotherapy for esophageal cancer","volume":"32","author":"Saito","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.ctro.2025.101011_b0050","article-title":"Patient-specific lymphocyte loss kinetics as biomarker of spleen dose in patients undergoing radiation therapy for upper abdominal malignancies","volume":"6","author":"Yalamanchali","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.radonc.2015.07.036","article-title":"Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer","volume":"116","author":"Trip","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0065","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.21037\/tcr-21-1765","article-title":"Association between unintentional splenic radiation and lymphopenia and high neutrophil\/lymphocyte ratio after radiotherapy in patients with esophageal cancer","volume":"10","author":"Sakaguchi","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ctro.2025.101011_b0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.adro.2018.02.005","article-title":"The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer","volume":"3","author":"Chin","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0075","unstructured":"The Royal College of Radiologists. Incidental irradiation of the spleen: RCR guidance. Lond R Coll Radiol 2021."},{"key":"10.1016\/j.ctro.2025.101011_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2020.10.025","article-title":"The spleen as an organ at risk in paediatric radiotherapy: a SIOP-Europe radiation oncology working group report","volume":"143","author":"Arunagiri","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2025.101011_b0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2018.06.002","article-title":"Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases","volume":"102","author":"Palacios","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0090","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2018.05.048","article-title":"MR-guided gated stereotactic radiation therapy delivery for lung, adrenal, and pancreatic tumors: a geometric analysis","volume":"102","author":"Van S\u00f6rnsen De Koste","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142608","article-title":"Spleen volume variation in patients with locally advanced non-small cell lung cancer receiving platinum-based chemo-radiotherapy","volume":"10","author":"Wen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2025.101011_b0100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028515","article-title":"Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease","volume":"101","author":"Kawashima","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ctro.2025.101011_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ijs.12022","article-title":"Changes in spleen size in patients with acute ischemic stroke: a pilot observational study","volume":"8","author":"Sahota","year":"2013","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ctro.2025.101011_b0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2020.07.045","article-title":"Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases","volume":"152","author":"van S\u00f6rnsen de Koste","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-022-00399-x","article-title":"Asplenia and spleen hypofunction","volume":"8","author":"Lenti","year":"2022","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.ctro.2025.101011_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023164","article-title":"Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort","volume":"6","author":"Cameron","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2025.101011_b0125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jrr\/rrae023","article-title":"The relationship between splenic dose and radiation-induced lymphopenia","volume":"65","author":"Ma","year":"2024","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.ctro.2025.101011_b0130","article-title":"Magnetic resonance imaging guided radiation therapy for splenomegaly: clinical experiences and technical tips","volume":"9","author":"Romano","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13014-021-01969-1","article-title":"Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy","volume":"16","author":"Reddy","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0140","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1200\/JCO.2017.76.1643","article-title":"Late infection-related mortality in asplenic survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"36","author":"Weil","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2022.7153","article-title":"Association of radiation and procarbazine dose with risk of colorectal cancer among survivors of hodgkin lymphoma","author":"Geurts","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109490","article-title":"RE: Venkatesulu et al. (Letter to the Editor)","author":"Ellsworth","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2025.101011_b0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): a systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0160","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.3390\/curroncol29100552","article-title":"Dose\u2013volume constraints for organs at risk in radiotherapy (CORSAIR): an \u201call-in-one\u201d multicenter\u2013multidisciplinary practical summary","volume":"29","author":"Bisello","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ctro.2025.101011_b0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2014.12.008","article-title":"Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer","volume":"220","author":"Simpson","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ctro.2025.101011_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270950","article-title":"Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy","volume":"17","author":"Castagnoli","year":"2022","journal-title":"PLoS One"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082500103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082500103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T17:07:35Z","timestamp":1758128855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082500103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S240563082500103X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101011","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in splenic volumes following stereotactic ablative radiotherapy (SABR) to adrenal tumors","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101011"}}